Your browser doesn't support javascript.
loading
Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering.
Michels, Kathryn R; Sheih, Alyssa; Hernandez, Susana A; Brandes, Alissa H; Parrilla, Don; Irwin, Blythe; Perez, Anai M; Ting, Hung-An; Nicolai, Christopher J; Gervascio, Timothy; Shin, Seungjin; Pankau, Mark D; Muhonen, Mason; Freeman, Jessica; Gould, Sarah; Getto, Rich; Larson, Ryan P; Ryu, Byoung Y; Scharenberg, Andrew M; Sullivan, Alessandra M; Green, Shon.
Afiliação
  • Michels KR; Immunology, Umoja Biopharma Inc, Seattle, Washington, USA kathryn.michels@umoja-biopharma.com.
  • Sheih A; Immunology, Umoja Biopharma Inc, Seattle, Washington, USA.
  • Hernandez SA; Immunology, Umoja Biopharma Inc, Seattle, Washington, USA.
  • Brandes AH; Immunology, Umoja Biopharma Inc, Seattle, Washington, USA.
  • Parrilla D; Immunology, Umoja Biopharma Inc, Seattle, Washington, USA.
  • Irwin B; Immunology, Umoja Biopharma Inc, Seattle, Washington, USA.
  • Perez AM; Immunology, Umoja Biopharma Inc, Seattle, Washington, USA.
  • Ting HA; Immunology, Umoja Biopharma Inc, Seattle, Washington, USA.
  • Nicolai CJ; Discovery, Umoja Biopharma, Seattle, Washington, USA.
  • Gervascio T; Office of Animal Care, Seattle Children's Hospital, Seattle, Washington, USA.
  • Shin S; Vector Biology, Umoja Biopharma, Seattle, Washington, USA.
  • Pankau MD; Process Development, Umoja Biopharma, Seattle, Washington, USA.
  • Muhonen M; MSAT, Umoja Biopharma, Boulder, Colorado, USA.
  • Freeman J; MSAT, Umoja Biopharma, Boulder, Colorado, USA.
  • Gould S; MSAT, Umoja Biopharma, Boulder, Colorado, USA.
  • Getto R; Umoja Biopharma, Seattle, Washington, USA.
  • Larson RP; Immunology, Umoja Biopharma Inc, Seattle, Washington, USA.
  • Ryu BY; Discovery, Umoja Biopharma, Seattle, Washington, USA.
  • Scharenberg AM; Umoja Biopharma, Seattle, Washington, USA.
  • Sullivan AM; Immunology, Umoja Biopharma Inc, Seattle, Washington, USA.
  • Green S; Immunology, Umoja Biopharma Inc, Seattle, Washington, USA.
J Immunother Cancer ; 11(3)2023 03.
Article em En | MEDLINE | ID: mdl-36918221
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Receptores de Antígenos Quiméricos Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Receptores de Antígenos Quiméricos Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article